08156 SINOPHARM TECH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 06/2024) | |||
Current | 0.15X | Oper Margin | 9.7% |
---|---|---|---|
LT Debt/Equity | N/A | Net Margin | N/A |
Total Debt/Equity | N/A | Return on Equity | N/A |
Price/Book | N/A | Return on Assets | N/A |
(HKD 0.250) | 2024-06 | 2023-06 | 2022-06 | 2021-06 | 2020-06 |
Net Profit (MHKD) | -19.70 | -10.64 | -88.00 | -106.34 | -161.08 |
---|---|---|---|---|---|
Net Profit Growth (%) | -85.2 | +87.9 | +17.3 | +34.0 | -244.2 |
Earnings Per Share (HKD) | -0.107 | -0.058 | -0.489 | -0.618 | -0.978 |
Earnings Per Share Growth (%) | -84.2 | +88.1 | +20.8 | +36.8 | -189.6 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | -1.086 | -0.940 | -0.919 | -0.788 | -0.425 |
Auditors' Opinion | Qualified | Qualified | Qualified | Unqualified # | Unqualified # |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 18.898 | 18.844 | +0.3 | 15.025 |
Operating Result | -4.458 | -4.262 | +4.6 | 16.3 |
Associates | 0 | 0 | N/A | -0.531 |
Profit Before Taxation | -4.458 | -2.239 | +99.1 | 15.769 |
Taxation | -0.01 | 0 | N/A | 0 |
Profit /( Loss) After Taxation | -4.448 | -2.239 | +98.7 | 15.769 |
Minority Interests | 1.065 | 0.637 | +67.2 | 0.361 |
Net Profit | -6.467 | -2.876 | +124.9 | 15.408 |
Earnings Per Share () | -0.0217 | -0.0157 | +38.2 | 0.0846 |
Announcement Date | 2025-02-28 | 2024-02-29 | NA | 2023-02-14 |
* Annualised
Last Update Time: 2025-07-22 21:40:25